| Trial ID: | L0783 |
| Source ID: | NCT03734510
|
| Associated Drug: |
Flaxseed
|
| Title: |
Evaluation of the Effects of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together on Hepatic Enzymes, Inflammatory Factors, Lipid Profile, Blood Glucose, Insulin Sensitivity, and Hepatic Steatosis Grade in Patients With Non-alcoholic
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Steatohepatitis
|
| Interventions: |
Dietary Supplement: Dietary Supplement: hesperidin and flaxseed;Dietary Supplement: Dietary Supplement: hesperidin;Dietary Supplement: Dietary Supplement: flaxseed;Other: control
|
| Outcome Measures: |
liver fibrosisnan
|
| Sponsor/Collaborators: |
National Nutrition and Food Technology Institute
|
| Gender: |
All
|
| Age: |
18 Years70 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
100
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
| Start Date: |
06/11/2018
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
Iran, Islamic Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT03734510
|
